Breaking News

BioDuro Opens New Lab in Shanghai

The specialized facility is designed to accelerate discovery and early development programs for conjugated drugs.

Author Image

By: Charlie Sternberg

Associate Editor

BioDuro, a global contract research, development, and manufacturing organization (CRDMO), has opened a new laboratory in the Waigaoqiao district/Free-Trade Zone of Shanghai, China, for highly potent compound synthesis at the hundred-gram scale. Operating within occupational exposure band 5 (OEB-5), this specialized facility is designed to accelerate discovery and early development programs for conjugated drugs, including antibody-drug conjugates (ADCs), peptide-drug conjugates (PDCs), and rad...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters